BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 23613270)

  • 1. A role for RUNX1 in hematopoiesis and myeloid leukemia.
    Ichikawa M; Yoshimi A; Nakagawa M; Nishimoto N; Watanabe-Okochi N; Kurokawa M
    Int J Hematol; 2013 Jun; 97(6):726-34. PubMed ID: 23613270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes.
    Koh CP; Wang CQ; Ng CE; Ito Y; Araki M; Tergaonkar V; Huang G; Osato M
    Leukemia; 2013 Sep; 27(9):1793-802. PubMed ID: 23817177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis.
    Kalev-Zylinska ML; Horsfield JA; Flores MV; Postlethwait JH; Vitas MR; Baas AM; Crosier PS; Crosier KE
    Development; 2002 Apr; 129(8):2015-30. PubMed ID: 11934867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RUNX1-EVI1 induces dysplastic hematopoiesis and acute leukemia of the megakaryocytic lineage in mice.
    Nakamura Y; Ichikawa M; Oda H; Yamazaki I; Sasaki K; Mitani K
    Leuk Res; 2018 Nov; 74():14-20. PubMed ID: 30278283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the runt homology domain of RUNX1 disrupts homeostasis of hematopoietic stem cells and induces progression to myelodysplastic syndrome.
    Matsuura S; Komeno Y; Stevenson KE; Biggs JR; Lam K; Tang T; Lo MC; Cong X; Yan M; Neuberg DS; Zhang DE
    Blood; 2012 Nov; 120(19):4028-37. PubMed ID: 22919028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.
    Sakurai M; Kunimoto H; Watanabe N; Fukuchi Y; Yuasa S; Yamazaki S; Nishimura T; Sadahira K; Fukuda K; Okano H; Nakauchi H; Morita Y; Matsumura I; Kudo K; Ito E; Ebihara Y; Tsuji K; Harada Y; Harada H; Okamoto S; Nakajima H
    Leukemia; 2014 Dec; 28(12):2344-54. PubMed ID: 24732596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AML1/Runx1 as a versatile regulator of hematopoiesis: regulation of its function and a role in adult hematopoiesis.
    Kurokawa M
    Int J Hematol; 2006 Aug; 84(2):136-42. PubMed ID: 16926135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AML1/RUNX1 functions as a cytoplasmic attenuator of NF-κB signaling in the repression of myeloid tumors.
    Nakagawa M; Shimabe M; Watanabe-Okochi N; Arai S; Yoshimi A; Shinohara A; Nishimoto N; Kataoka K; Sato T; Kumano K; Nannya Y; Ichikawa M; Imai Y; Kurokawa M
    Blood; 2011 Dec; 118(25):6626-37. PubMed ID: 22021368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia.
    Engel ME; Hiebert SW
    Cancer Treat Res; 2010; 145():127-47. PubMed ID: 20306249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical role of RUNX1 in governing megakaryocyte-primed hematopoietic stem cell differentiation.
    Wang C; Tu Z; Cai X; Wang W; Davis AK; Nattamai K; Paranjpe A; Dexheimer P; Wu J; Huang FL; Geiger H; Huang G; Zheng Y
    Blood Adv; 2023 Jun; 7(11):2590-2605. PubMed ID: 36661340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells.
    Redondo Monte E; Wilding A; Leubolt G; Kerbs P; Bagnoli JW; Hartmann L; Hiddemann W; Chen-Wichmann L; Krebs S; Blum H; Cusan M; Vick B; Jeremias I; Enard W; Theurich S; Wichmann C; Greif PA
    Oncogene; 2020 Apr; 39(15):3195-3205. PubMed ID: 32115572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease.
    Erickson PF; Dessev G; Lasher RS; Philips G; Robinson M; Drabkin HA
    Blood; 1996 Sep; 88(5):1813-23. PubMed ID: 8781439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of NIPBL leads to impaired RUNX1 expression and haematopoietic defects.
    Mazzola M; Pezzotta A; Fazio G; Rigamonti A; Bresciani E; Gaudenzi G; Pelleri MC; Saitta C; Ferrari L; Parma M; Fumagalli M; Biondi A; Cazzaniga G; Marozzi A; Pistocchi A
    J Cell Mol Med; 2020 Jun; 24(11):6272-6282. PubMed ID: 32323916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RUNX1: A microRNA hub in normal and malignant hematopoiesis.
    Rossetti S; Sacchi N
    Int J Mol Sci; 2013 Jan; 14(1):1566-88. PubMed ID: 23344057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells.
    Zaidi SK; Perez AW; White ES; Lian JB; Stein JL; Stein GS
    Oncotarget; 2017 Jun; 8(25):39994-40005. PubMed ID: 28611288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y; Harada H
    J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AML1/Runx1 negatively regulates quiescent hematopoietic stem cells in adult hematopoiesis.
    Ichikawa M; Goyama S; Asai T; Kawazu M; Nakagawa M; Takeshita M; Chiba S; Ogawa S; Kurokawa M
    J Immunol; 2008 Apr; 180(7):4402-8. PubMed ID: 18354160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs.
    Mandoli A; Singh AA; Prange KHM; Tijchon E; Oerlemans M; Dirks R; Ter Huurne M; Wierenga ATJ; Janssen-Megens EM; Berentsen K; Sharifi N; Kim B; Matarese F; Nguyen LN; Hubner NC; Rao NA; van den Akker E; Altucci L; Vellenga E; Stunnenberg HG; Martens JHA
    Cell Rep; 2016 Nov; 17(8):2087-2100. PubMed ID: 27851970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.
    Cheng CK; Chan NP; Wan TS; Lam LY; Cheung CH; Wong TH; Ip RK; Wong RS; Ng MH
    Haematologica; 2016 Apr; 101(4):448-57. PubMed ID: 26802049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.